search
Back to results

Radiofrequency Neurotomy for Chronic Facet Joint Related Neck Pain

Primary Purpose

Neck Pain

Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Radiofrequency neurotomy
Sham treatment
Sponsored by
Oslo University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neck Pain focused on measuring radiofrequency neurotomy, zygapophyseal joint

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • Min 18 years and Maximum 80 years
  • Read and understand Norwegian
  • Stable neck pain >12 months, with or without unilateral headache
  • Average of worst pain intensity last three days ≥ 4 out of maximum 10
  • Neck Disability Index >15 points or > 30 percentage points.
  • At least two predictive blocks ≥ 50% pain relief 30 to 60 minutes after lidocaine and 30 to 180 minutes after bupivacaine .

Exclusion Criteria:

  • Serious cervical pathology (acute cervical disc herniation, radiculopathy, myelopathy, spinal anomalies and chronic widespread pain
  • Opioid consumption > 50 morphine equivalents/day
  • Ongoing litigation process and applying for disability insurance/benefits
  • Serious psychiatric disorder (DSM-IV-TR) diagnosed at a psychiatric unit, including suicidal thoughts and somatization (from Hopkins Symptom Check List 25 ≥ 2.5)
  • Ongoing addictive behavior ( diagnostic criteria in Statistical Manual, 4th Edition)
  • Unstable medical condition (ASA 4, serious vascular disease like unstable angina)
  • Bacterial infection
  • Malignancy
  • Chronic generalized pain
  • Hypersensitive to contrast agents or local anesthetics
  • Pregnancy
  • Bleeding diathesis
  • Previously radiofrequency neurotomy

Sites / Locations

  • Department for Pain and Complex DisordersRecruiting
  • Department of Pain Management and Research Oslo University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Radiofrequency neurotomy group

Sham group

Arm Description

Unilateral radiofrequency neurotomy of medial branches to the dorsal ramus at one or two cervical levels

Unilateral sham treatment of medial branches to the dorsal ramus at one or two cervical levels

Outcomes

Primary Outcome Measures

Change in neck function after RF neurotomy vs sham treatment
Two independent group comparison of change of Neck Disability Index triplicate scores -continuous variable 0-100 - from three consecutive days)
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)

Secondary Outcome Measures

Change in neck function after RF neurotomy vs sham treatment
Two independent group comparison of change of Neck Disability Index triplicate scores -continuous variable 0-100 - from three consecutive days)
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Change in health related quality of life after RF neurotomy vs sham treatment
Two independent group comparison of change of EuroQuol-5-Dimensions Index scores (continuous variable from -0.59 to 1.00)
Change in health related quality of life after RF neurotomy vs sham treatment
Two independent group comparison of change of EuroQuol-5-Dimensions Index scores (continuous variable from -0.59 to 1.00)
Change in drug consumption after RF neurotomy vs sham treatment
Two independent group comparison of change of the numbers of analgesic drugs (continuous variable)
Change in drug consumption after RF neurotomy vs sham treatment
Two independent group comparison of change of the numbers of analgesic drugs (continuous variable)
Change in number of neck/pain treatments after RF neurotomy vs sham treatment
Two independent group comparison of change of the numbers of neck/pain treatments (continuous variable)
How highly positive response to test block influences neck function after RF treatment
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >15% reduction of Neck disability Score (categorical variable) after RF neurotomy
How moderately positive response to test block influences neck function after RF treatment
Regression analysis on how ≥50% and <80% pain relief (independent categorical variable) predicts >15% reduction of Neck disability Score (categorical variable) after RF neurotomy
How highly positive response to test block influences 30% pain relief after RF treatment
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >30% reduction in pain intensity (categorical variable) after RF neurotomy
How moderately positive response to test block influences 30% pain relief after RF treatment
Regression analysis on how ≥50% and <80% pain relief (independent categorical variable) predicts >30% reduction in pain intensity (categorical variable) after RF neurotomy
How highly positive response to test block influences 50% pain relief after RF treatment
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >50% reduction in pain intensity (categorical variable) after RF neurotomy
How moderately positive response to test block influences 50% pain relief after RF treatment
Regression analysis on how ≥50 and <80% pain relief (independent categorical variable) predicts >50% reduction in pain intensity (categorical variable) after RF neurotomy
How catastrophizing influences neck function after RF treatment.
Regression analysis on how Pain Catastrophizing Scale score ≥30 (independent categorical variable) predict ≥ 15% reduction of Neck Disability Score (categorical variable) after RF neurotomy vs Pain Catastrophizing Scale score < 30
How catastrophizing influences pain relief after RF treatment.
Regression analysis on how Pain Catastrophizing Scale scores ≥30 (independent categorical variable) predict >30% reduction in pain intensity (categorical variable) after RF neurotomy vs Pain Catastrophizing Scale scores < 30
Change in mental distress after RF neurotomy vs sham treatment.
Two independent group comparison of change in Hopkin Symptom Check List (HSCL 25) sumscore which is a continuous variable on anxiety and depressive symptoms, ranging from 1 (normal) to 4 (worse)
Change in mental distress after RF neurotomy vs sham treatment.
Two independent group comparison of change in Hopkin Symptom Check List (HSCL 25) sumscore which is a continuous variable on anxiety and depressive symptoms, ranging from 1 (normal) to 4 (worse)
Change in sleep disturbances after RF neurotomy vs sham treatment.
Two independent group comparison of change in sleep. Sleep Subscale in Neck Disability Index part 7. A continuous variable based on a 6 point scale ranging from 0 to 6 where 0 is no problem and 6 i severe insomnia.
Change in sleep disturbances after RF neurotomy vs sham treatment.
Two independent group comparison of change in sleep. Sleep Subscale in Neck Disability Index part 7. A continuous variable based on a 6 point scale ranging from 0 to 6 where 0 is no problem and 6 i severe insomnia.

Full Information

First Posted
February 20, 2017
Last Updated
December 31, 2020
Sponsor
Oslo University Hospital
Collaborators
St. Olavs Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03066960
Brief Title
Radiofrequency Neurotomy for Chronic Facet Joint Related Neck Pain
Official Title
Long-term Efficacy of Radiofrequency Neurotomy for Chronic Zygapophysial (Facet) Joint Related Neck Pain
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 8, 2018 (Actual)
Primary Completion Date
December 14, 2022 (Anticipated)
Study Completion Date
December 14, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital
Collaborators
St. Olavs Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The researchers are planning a two-center double blind, sham-controlled randomized trial (N: 44) to assess the long term efficacy of RF neurotomy of cervical medial branches. Patients with chronic unilateral neck pain who are found eligible and achieve ≥80% pain relief of two predictive and comparative test blocks, will be included in the primary analysis. Those patients with ≥50% and < 80% pain relief will be included in a secondary analysis to examine whether a strict selection better predicts the effect of RF neurotomy. After 6 months sham-treated patients may also be offered active RF treatment. Demographic and clinical data will be recorded at baseline while primary and secondary outcome measurements are recollected after 1, 3, 6, 9 and 12 months. Primary outcome measurements include self reported neck function (NDI) and pain relief after 6 months.
Detailed Description
Chronic neck pain represents a common health problem. The mechanisms appear to be multifactorial. Researchers have suggested a disturbed interplay between the neck muscles and the facet joints. In Europe and the US radiofrequency neurotomy (RFN) has become a common treatment. The evidence base, however, is still insufficient. Thus, a double blind, sham-controlled, randomized, two-center trial will be carried out including 44 participants. To simplify the data collection a digital internet based program will be used. Patients with chronic unilateral neck pain, referred to Oslo University Hospital or St Olavs University Hospital and not responding to non-interventional treatment, will be screened. Those who are found eligible and achieve ≥80% pain relief after predictive and comparative test blocks, will be included in the primary analysis. Patients with ≥50% and < 80% pain relief will be included in a secondary analysis to examine whether a strict selection better predicts the effect of RF neurotomy. After 6 months participants who received sham and still suffers from neck pain, will be offered unblinded RF ablation and additional 12 month unblinded follow up if the results support this treatment. Demographic and clinical data will be recorded at baseline. The primary and secondary outcome measurements (including blinding test) are recollected after 1, 3, 6, 9 and 12 months. Primary outcome measurements include self reported neck function (NDI) and pain relief after 6 months. Regression analyses will be used to identify how ≥80% vs. ≥50 and <80% pain relief of two test blocks and pain catastrophizing (Pain Catastrophizing Scale = PCS) predict response to RF neurotomy. If RF neurotomy is found superior to sham treatment, this may be implemented in the national treatment program for selected patients with chronic neck pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neck Pain
Keywords
radiofrequency neurotomy, zygapophyseal joint

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
44 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Radiofrequency neurotomy group
Arm Type
Active Comparator
Arm Description
Unilateral radiofrequency neurotomy of medial branches to the dorsal ramus at one or two cervical levels
Arm Title
Sham group
Arm Type
Sham Comparator
Arm Description
Unilateral sham treatment of medial branches to the dorsal ramus at one or two cervical levels
Intervention Type
Procedure
Intervention Name(s)
Radiofrequency neurotomy
Intervention Description
RF neurotomy represents a nerve destructive, coagulating technique affecting the conduction through all nerve fibers.
Intervention Type
Procedure
Intervention Name(s)
Sham treatment
Intervention Description
Sham treatment represents no coagulation of the nerve and will not affect the nerve conduction.
Primary Outcome Measure Information:
Title
Change in neck function after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of Neck Disability Index triplicate scores -continuous variable 0-100 - from three consecutive days)
Time Frame
6 months
Title
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in neck function after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of Neck Disability Index triplicate scores -continuous variable 0-100 - from three consecutive days)
Time Frame
12 months
Title
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Time Frame
1 month
Title
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Time Frame
3 months
Title
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Time Frame
9 months
Title
Change in pain intensity (numeric pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (triplicate values from three consecutive days on a numeric pain scale 0-10 which provides a continuous variable)
Time Frame
12 months
Title
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Time Frame
1 month
Title
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Time Frame
3 months
Title
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Time Frame
6 months
Title
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Time Frame
9 months
Title
Change in pain intensity (categorical pain scale) after RF neurotomy vs sham treatment
Description
Two independent group comparison of change in pain intensity (categorical 6-point pain scale wth the alternatives worse, unchanged, <50% reduced, ≥50% reduced, and pain free which provides a categorial variable)
Time Frame
12 months
Title
Change in health related quality of life after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of EuroQuol-5-Dimensions Index scores (continuous variable from -0.59 to 1.00)
Time Frame
6 months
Title
Change in health related quality of life after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of EuroQuol-5-Dimensions Index scores (continuous variable from -0.59 to 1.00)
Time Frame
12 months
Title
Change in drug consumption after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of the numbers of analgesic drugs (continuous variable)
Time Frame
6 months
Title
Change in drug consumption after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of the numbers of analgesic drugs (continuous variable)
Time Frame
12 months
Title
Change in number of neck/pain treatments after RF neurotomy vs sham treatment
Description
Two independent group comparison of change of the numbers of neck/pain treatments (continuous variable)
Time Frame
6 months
Title
How highly positive response to test block influences neck function after RF treatment
Description
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >15% reduction of Neck disability Score (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How moderately positive response to test block influences neck function after RF treatment
Description
Regression analysis on how ≥50% and <80% pain relief (independent categorical variable) predicts >15% reduction of Neck disability Score (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How highly positive response to test block influences 30% pain relief after RF treatment
Description
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >30% reduction in pain intensity (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How moderately positive response to test block influences 30% pain relief after RF treatment
Description
Regression analysis on how ≥50% and <80% pain relief (independent categorical variable) predicts >30% reduction in pain intensity (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How highly positive response to test block influences 50% pain relief after RF treatment
Description
Regression analysis on how ≥80% pain relief (independent categorical variable) predicts >50% reduction in pain intensity (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How moderately positive response to test block influences 50% pain relief after RF treatment
Description
Regression analysis on how ≥50 and <80% pain relief (independent categorical variable) predicts >50% reduction in pain intensity (categorical variable) after RF neurotomy
Time Frame
6 months
Title
How catastrophizing influences neck function after RF treatment.
Description
Regression analysis on how Pain Catastrophizing Scale score ≥30 (independent categorical variable) predict ≥ 15% reduction of Neck Disability Score (categorical variable) after RF neurotomy vs Pain Catastrophizing Scale score < 30
Time Frame
6 months
Title
How catastrophizing influences pain relief after RF treatment.
Description
Regression analysis on how Pain Catastrophizing Scale scores ≥30 (independent categorical variable) predict >30% reduction in pain intensity (categorical variable) after RF neurotomy vs Pain Catastrophizing Scale scores < 30
Time Frame
6 months
Title
Change in mental distress after RF neurotomy vs sham treatment.
Description
Two independent group comparison of change in Hopkin Symptom Check List (HSCL 25) sumscore which is a continuous variable on anxiety and depressive symptoms, ranging from 1 (normal) to 4 (worse)
Time Frame
6 months
Title
Change in mental distress after RF neurotomy vs sham treatment.
Description
Two independent group comparison of change in Hopkin Symptom Check List (HSCL 25) sumscore which is a continuous variable on anxiety and depressive symptoms, ranging from 1 (normal) to 4 (worse)
Time Frame
12 months
Title
Change in sleep disturbances after RF neurotomy vs sham treatment.
Description
Two independent group comparison of change in sleep. Sleep Subscale in Neck Disability Index part 7. A continuous variable based on a 6 point scale ranging from 0 to 6 where 0 is no problem and 6 i severe insomnia.
Time Frame
6 months
Title
Change in sleep disturbances after RF neurotomy vs sham treatment.
Description
Two independent group comparison of change in sleep. Sleep Subscale in Neck Disability Index part 7. A continuous variable based on a 6 point scale ranging from 0 to 6 where 0 is no problem and 6 i severe insomnia.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Min 18 years and Maximum 80 years Read and understand Norwegian Stable neck pain >12 months, with or without unilateral headache Average of worst pain intensity last three days ≥ 4 out of maximum 10 Neck Disability Index >15 points or > 30 percentage points. At least two predictive blocks ≥ 50% pain relief 30 to 60 minutes after lidocaine and 30 to 180 minutes after bupivacaine . Exclusion Criteria: Serious cervical pathology (acute cervical disc herniation, radiculopathy, myelopathy, spinal anomalies and chronic widespread pain Opioid consumption > 50 morphine equivalents/day Ongoing litigation process and applying for disability insurance/benefits Serious psychiatric disorder (DSM-IV-TR) diagnosed at a psychiatric unit, including suicidal thoughts and somatization (from Hopkins Symptom Check List 25 ≥ 2.5) Ongoing addictive behavior ( diagnostic criteria in Statistical Manual, 4th Edition) Unstable medical condition (ASA 4, serious vascular disease like unstable angina) Bacterial infection Malignancy Chronic generalized pain Hypersensitive to contrast agents or local anesthetics Pregnancy Bleeding diathesis Previously radiofrequency neurotomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gunnvald Kvarstein, Dr. Med
Phone
+47 92295309
Email
gunnvald.kvarstein@uit.no
First Name & Middle Initial & Last Name or Official Title & Degree
Bård Lundeland, PhD
Phone
+47 41238959
Email
'Bård Lundeland' <baalun@ous-hf.no>
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gunnvald Kvarstein, Dr. Med
Organizational Affiliation
Oslo University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department for Pain and Complex Disorders
City
Trondheim
State/Province
Torgarden
ZIP/Postal Code
3250
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Petter Borchgrevink, PhD
Phone
+4772822500
Email
petter.borchgrevink@ntnu.no
Facility Name
Department of Pain Management and Research Oslo University Hospital
City
Oslo
ZIP/Postal Code
4950
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gunnvald Kvarstein, PhD
Phone
+47923026161
Email
gunnvald.kvarstein@uit.no
First Name & Middle Initial & Last Name & Degree
Bård Lundeland, PhD
Phone
4+4723026161
Email
bard.lundeland@ous-hf.no

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual Participant Data Sharing Plan. In accordance with the general data sharing policy at OUH, the deidentified, individual data can be made available for external researchers from 9 months to 5 years after publication. However, to get access the researchers need to provide a methodologically sound proposal in accordance with the institutional guidelines and sign a data access agreement.
IPD Sharing Time Frame
From 9 months to 5 years after publication
IPD Sharing Access Criteria
To get access the researchers need to provide a methodologically sound proposal in accordance with the institutional guidelines and sign a data access agreement.

Learn more about this trial

Radiofrequency Neurotomy for Chronic Facet Joint Related Neck Pain

We'll reach out to this number within 24 hrs